Basics Zevra Therapeutics, Inc. IPO Date: April 13, 2015 Sector: Healthcare Industry: Biotech Market Cap: $502.41M Activated in VL: True Average Daily Range Avg Daily Range: $0.16 | 2.49% Avg Daily Range (30 D): $0.21 | 2.04% Avg Daily Range (90 D): $0.21 | 2.19% Institutional Daily Volume Avg Daily Volume: .44M Avg Daily Volume (30 D): 1.26M Avg Daily Volume (90 D): .93M Trade Size Avg Trade Size (Sh.): 91 Avg Trade Size (Sh.) (30 D): 83 Avg Trade Size (Sh.) (90 D): 83 Institutional Trades Total Inst.Trades: 134 Avg Inst. Trade: $1.35M Avg Inst. Trade (30 D): $1.05M Avg Inst. Trade (90 D): $1.09M Avg Inst. Trade Volume: .17M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.65M Avg Closing Trade (30 D): $1.05M Avg Closing Trade (90 D): $1.07M Avg Closing Volume: 201.97K     News Feb 27, 2025 @ 12:30 PM Zevra Therapeutics Enters Agreement to Sell its Ra... Source: Globe Newswire Dec 6, 2024 @ 10:00 PM Zevra Therapeutics Announces Organizational Change... Source: N/A Nov 21, 2024 @ 9:51 PM Zevra Therapeutics Announces U.S. Commercial Avail... Source: N/A Nov 11, 2024 @ 9:36 PM Zevra Therapeutics to Present Data Demonstrating R... Source: Zevra Therapeutics, Inc. Aug 2, 2024 @ 9:50 PM FDA Advisory Committee Votes Favorably that the Da... Source: Zevra Therapeutics, Inc. Financials   TTM Q1 2025 Q4 2024 Basic EPS $1.24 $-.06 $-.69 Diluted EPS $1.21 $-.05 Revenue $ 25.88M $ 20.4M $ 12.04M Gross Profit $ $ $ Net Income / Loss $ 74.71M $ -3.1M $ -35.74M Operating Income / Loss $ -71.04M $ -5.36M $ -15.42M Cost of Revenue $ $ $ Net Cash Flow $ 9.71M $ 3.93M $ -20.93M PE Ratio 6.96     Splits Dec 28, 2020:   1:16